These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1680478)

  • 1. 15th International Cancer Congress. Proceedings of the satellite symposium on recent advances of Bestatin (ubenimex), Hamburg, August 19, 1990.
    Biomed Pharmacother; 1991; 45(2-3):49-124. PubMed ID: 1680478
    [No Abstract]   [Full Text] [Related]  

  • 2. Bestatin (Ubenimex)--a low molecular immunomodifier. Papers from a workshop at the 16th International Congress of Chemotherapy. Jerusalem, June 11-16, 1989. Proceedings.
    Acta Oncol; 1990; 29(6):793-831. PubMed ID: 1977424
    [No Abstract]   [Full Text] [Related]  

  • 3. Ubenimex in the treatment of acute nonlymphocytic leukemia in adults.
    Urabe A; Mutoh Y; Mizoguchi H; Takaku F; Ogawa N
    Ann Hematol; 1993 Aug; 67(2):63-6. PubMed ID: 8347731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of ubenimex (Bestatin): clinical research.
    Ota K
    Biomed Pharmacother; 1991; 45(2-3):55-60. PubMed ID: 1912370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological effect of bestatin against rat ascites hepatomas and enhancement of interferon production].
    Satoh H
    Jpn J Antibiot; 1984 Apr; 37(4):593-6. PubMed ID: 6206251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity.
    Inoi K; Goto S; Nomura S; Isobe K; Nawa A; Okamoto T; Tomoda Y
    Anticancer Res; 1995; 15(5B):2081-7. PubMed ID: 8572606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bestatin treatment and the peripheral lymphocyte population in cancer patients.
    Blomgren H; Strender LE; Edsmyr F
    Recent Results Cancer Res; 1980; 75():133-8. PubMed ID: 7232824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Double blind controlled study of ubenimex (Bestatin) against squamous cell lung cancer--a multicenter cooperative study].
    Furuse K; Fukuoka M; Genka K; Kato H; Tsubura E; Ohta M; Nakai H; Kinuwaki E; Nakano M; Ishikawa S
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1187-94. PubMed ID: 8333747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of small molecular microbial products modulating immune responses and bestatin.
    Umezawa H
    Recent Results Cancer Res; 1980; 75():115-25. PubMed ID: 7232823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of chronic adult T-cell leukemia with ubenimex.
    Okamura T; Shibuya T; Harada M; Niho Y
    Acta Haematol; 1992; 87(1-2):94-7. PubMed ID: 1350160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis by ubenimex (Bestatin) in human non-small-cell lung cancer cell lines.
    Ezawa K; Minato K; Dobashi K
    Biomed Pharmacother; 1996; 50(6-7):283-9. PubMed ID: 8952869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of bestatin on the growth of human leukemic cells.
    Sakurada K; Imamura M; Kobayashi M; Tachibana N; Abe K; Tanaka M; Okabe M; Morioka M; Kasai M; Sugiura T
    Acta Oncol; 1990; 29(6):799-802. PubMed ID: 2223152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled study of chemoimmunotherapy with bestatin of acute nonlymphocytic leukemia in adults.
    Ota K; Ogawa N
    Biomed Pharmacother; 1990; 44(2):93-101. PubMed ID: 2224060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in cancer patient management. Proceedings of the 15th Cancer Congress Satellite Symposium. August 21, 1990, Hamburg, Germany.
    Semin Oncol; 1991 Feb; 18(1 Suppl 2):1-69. PubMed ID: 1671536
    [No Abstract]   [Full Text] [Related]  

  • 15. Bestatin administration and the change in cellular immunity.
    Yamagishi H; Naito K; Ueda Y; Itoi S; Kohnosu H; Kobayashi M; Kubo H; Matsuda A; Oka T
    Biomed Pharmacother; 1991; 45(2-3):117-20. PubMed ID: 1912367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of ubenimex (bestatin) on the invasion of uterine cervical carcinoma cells and their production and activation of gelatinase A.
    Ueda M; Ueki M; Fujii H; Yoshizawa K; Nakajima M
    J Med; 1997; 28(3-4):175-90. PubMed ID: 9355022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ubenimex on a CD5-CD13+ CLL patient with an aggressive clinical course.
    Horikoshi A; Irie T; Ishizuka H; Ohkubo T; Hosokawa Y; Sawada S
    Int J Hematol; 2000 Oct; 72(3):384-5. PubMed ID: 11185999
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement by ubenimex (bestatin) of host resistance to Candida albicans infection.
    Aoyagi K; Itoh N; Abe F; Abe S; Uchida K; Ishizuka M; Takeuchi T; Yamaguchi H
    J Antibiot (Tokyo); 1992 Nov; 45(11):1778-84. PubMed ID: 1468987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the antitumor effect of an inhibitor against cell surface enzyme (Bestatin)].
    Sonoyama T; Terata N; Matsumoto H; Nozaki A; Kimura K; Kurioka H; Hashimoto I; Tsunoda F; Kodama M
    Nihon Gan Chiryo Gakkai Shi; 1982 Aug; 17(5):1264-9. PubMed ID: 6984058
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of bestatin (NK-421) supplementing radiotherapy in the treatment of lung cancer].
    Hamada F; Imajo Y; Inomata Y; Ichiyanagi A; Ashida C; Gose K; Imanaka K; Takada Y; Kimura S; Ogawa Y
    Nihon Gan Chiryo Gakkai Shi; 1983 Aug; 18(5):1175-80. PubMed ID: 6663170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.